1. Leo ME, Bilhartz DL, Bergstralh EJ & Oesterling JE. Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an accurate indicator of disease status? Journal of Urology 1991;145:802-6
2. Rifkin MD, Kurtz AB, Choi HY & Goldberg BB. Endoscopic ultrasonic evaluation of the prostate using a transrectal probe : Prospective evaluation and acoustic characterization. Radiology 1983;149:265-271
3. Lee N, Fawaaz R, Olsson CA, Benson MC, Petrylak CP, Schiff PB, Bagiella E, Singh A & Ennis RD. Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients. International Journal of Oncology, Biology, Physics 2000;48:1443-6
4. Gleave M, Coupland D, Drachenberg D, Cohen C, Kwong S, Goldenberg SL & Sullivan LD. Ability of Serum Prostate-Specific Antigen Levels to Predict Normal Bone Scans in Patients with Newly Diagnosed Prostate Cancer. Urology 1996;47(5):706-12
5. Kemp PM, Maguire GA, Bird NJ. Which patients with prostatic carcinoma require a staging bone scan? British Journal of Urology 1997;79:611-4
6. Chybowski FM, Larson Keller JJ, Bergstralh EJ & Oesterling JE. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate Specific Antigen is superior to all other clinical parameters. Journal of Urology 1991;145:313-8
7. www.cancerbacup.org.uk. Current issues in the treatment of metastatic prostate cancer. 2001